IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Piramal Acquires U.S. Firm

8:14 AM MST | March 9, 2009

Indian pharmaceutical company Piramal Healthcare (Mumbai), formerly known as Nicholas Piramal, says it has completed the acquisition of Minrad International (Orchard Park, NY) for about $40 million. The deal calls for shareholders of Minrad, a producer of generics inhalation anesthetics, to receive $0.12/share. Minrad will operate as a Piramal wholly owned subsidiary. Piramal has sales of about $580 million and a portfolio including nine therapeutic areas. The company is also a custom manufacturer, with assets in Asia, Europe, and North America. The acquisition...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa